Oaktree Acquisition Corp. III Life Sciences (OACC) EPS (Basic) (2025 - 2026)
Oaktree Acquisition Corp. III Life Sciences filings provide 2 years of EPS (Basic) readings, the most recent being $0.06 for Q1 2026.
- Quarterly EPS (Basic) fell 14.29% to $0.06 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $0.3 through Mar 2026, changed N/A year-over-year, with the annual reading at $0.3 for FY2025, 150.0% up from the prior year.
- EPS (Basic) hit $0.06 in Q1 2026 for Oaktree Acquisition Corp. III Life Sciences, down from $0.08 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.08 in Q2 2025 and bottomed at $0.06 in Q1 2026.